VOYA Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Sell |
20,056
-10,810
| -35% | -$299K | ﹤0.01% | 1846 |
|
|
2025
Q1 | $686K | Buy |
30,866
+10,878
| +54% | +$242K | ﹤0.01% | 1726 |
|
|
2024
Q4 | $395K | Buy |
19,988
+2,870
| +17% | +$56.8K | ﹤0.01% | 2049 |
|
|
2024
Q3 | $428K | Buy |
17,118
+4,344
| +34% | +$109K | ﹤0.01% | 2085 |
|
|
2024
Q2 | $238K | Buy |
12,774
+2,199
| +21% | +$41.1K | ﹤0.01% | 2380 |
|
|
2024
Q1 | $209K | Sell |
10,575
-2,183
| -17% | -$43.1K | ﹤0.01% | 2432 |
|
|
2023
Q4 | $224K | Sell |
12,758
-372
| -3% | -$6.53K | ﹤0.01% | 2526 |
|
|
2023
Q3 | $228K | Hold |
13,130
| – | – | ﹤0.01% | 2472 |
|
|
2023
Q2 | $185K | Buy |
13,130
+289
| +2% | +$4.07K | ﹤0.01% | 2618 |
|
|
2023
Q1 | $138K | Sell |
12,841
-8,600
| -40% | -$92.5K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $321K | Sell |
21,441
-2,609
| -11% | -$39.1K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $309K | Buy |
24,050
+12,122
| +102% | +$156K | ﹤0.01% | 2328 |
|
|
2022
Q2 | $116K | Hold |
11,928
| – | – | ﹤0.01% | 2579 |
|
|
2022
Q1 | $119K | Hold |
11,928
| – | – | ﹤0.01% | 2489 |
|
|
2021
Q4 | $140K | Buy |
11,928
+100
| +0.8% | +$1.17K | ﹤0.01% | 2606 |
|
|
2021
Q3 | $135K | Hold |
11,828
| – | – | ﹤0.01% | 2673 |
|
|
2021
Q2 | $165K | Sell |
11,828
-136
| -1% | -$1.9K | ﹤0.01% | 2658 |
|
|
2021
Q1 | $221K | Buy |
11,964
+581
| +5% | +$10.7K | ﹤0.01% | 2487 |
|
|
2020
Q4 | $201K | Buy |
+11,383
| New | +$201K | ﹤0.01% | 2423 |
|